There were 684 press releases posted in the last 24 hours and 150,797 in the last 365 days.

Global Obesity Market and Competitive Landscape 2014-2018 & Forecast to 2023

/EIN News/ -- Dublin, Oct. 12, 2018 (GLOBE NEWSWIRE) -- The "Global Obesity Market and Competitive Landscape - 2018" report has been added to's offering.

Global Obesity Market and Competitive Landscape - 2018, provides comprehensive insights into Obesity pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Obesity market size and drug sales. This research also provides insights into Obesity epidemiology and late stage pipeline.

The research is classified into following sections - Obesity overview with definitions, symptoms, etiology, diagnosis, treatment options; Obesity pipeline insights covering late stage clinical trials pipeline; Obesity prevalence trends by countries; Obesity market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries.

Research Scope:

  • Obesity pipeline: Find out the drugs in clinical trials for Obesity by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Obesity epidemiology: Find out the prevalence of Obesity by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2023
  • Obesity products: Identify key products marketed and prescribed for Obesity by brand name, by molecule, by company, by branded / generic, by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Obesity market size: Find out the market size for Obesity drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2014
  • Obesity drug sales: Find out the sales of Obesity drugs by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
  • Obesity drugs sales forecast: Sales forecast for Obesity drugs to 2023 by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Obesity market share analysis: Find out the market shares of Obesity drugs and outlook by countries - US, Europe, Germany, France, Italy, Spain, UK, Japan

Benefits of this Research:

  • Evaluate commercial market opportunities for Obesity drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Obesity market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Obesity market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies

Key Topics Covered:

1. Obesity: Disease Overview
1.1. Obesity Symptoms
1.2. Obesity Etiology
1.3. Obesity Diagnosis
1.4. Obesity Treatment Options

2. Obesity Pipeline Insights
2.1. Obesity Phase 3 Clinical Trials
2.2. Obesity Phase 2 Clinical Trials
2.3. Obesity Phase 1 Clinical Trials

3. Obesity Epidemiology Analysis

4. US Obesity Market Insights
4.1. Marketed Products for Obesity in US
4.2. US Obesity Market Size & Forecast
4.3. US Obesity Product Sales Forecast
4.4. US Obesity Market Share Analysis

5. Germany Obesity Market Insights
5.1. Marketed Products for Obesity in Germany
5.2. Germany Obesity Market Size & Forecast
5.3. Germany Obesity Product Sales Forecast
5.4. Germany Obesity Market Share Analysis

6. France Obesity Market Insights
6.1. Marketed Products for Obesity in France
6.2. France Obesity Market Size & Forecast
6.3. France Obesity Product Sales Forecast
6.4. France Obesity Market Share Analysis

7. Italy Obesity Market Insights
7.1. Marketed Products for Obesity in Italy
7.2. Italy Obesity Market Size & Forecast
7.3. Italy Obesity Product Sales Forecast
7.4. Italy Obesity Market Share Analysis

8. Spain Obesity Market Insights
8.1. Marketed Products for Obesity in Spain
8.2. Spain Obesity Market Size & Forecast
8.3. Spain Obesity Product Sales Forecast
8.4. Spain Obesity Market Share Analysis

9. UK Obesity Market Insights
9.1. Marketed Products for Obesity in UK
9.2. UK Obesity Market Size & Forecast
9.3. UK Obesity Product Sales Forecast
9.4. UK Obesity Market Share Analysis

10. Europe Obesity Market Insights
10.1. Europe Obesity Market Size & Forecast
10.2. Europe Obesity Product Sales Forecast
10.3. Europe Obesity Market Share Analysis

11. Japan Obesity Market Insights
11.1. Marketed Products for Obesity in Japan
11.2. Japan Obesity Market Size & Forecast
11.3. Japan Obesity Product Sales Forecast
11.4. Japan Obesity Market Share Analysis

12. Global Obesity Market Insights
12.1. Global Obesity Market Size & Forecast
12.2. Global Obesity Product Sales Forecast
12.3. Global Obesity Market Share Analysis

13. Research Methodology

For more information about this report visit

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

         Laura Wood, Senior Press Manager
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Anti-Obesity Drugs


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.